[Edaily Starin Choi Hee-jae Reporter] The movie "Spider-Man: Brand New Day" kicked off its box office run with an overwhelming opening weekend. A scene from the movie “Spider-Man: Brand New Day” (Photo courtesy of Sony Pictures) According to the Korean Film Council’s integrated computer network on the 30th, “Spider-Man: A Brand New Day” (Spider-Man 4) drew 688,381 viewers on its opening day, the 29th, overtaking “Hope” to claim the No. 1 spot at the box office. The cumulative audience count stands at 689,635. This marks the best opening record among films released this year and the highest opening-day total in the entire “TomSpidey” (Spider-Man starring Tom Holland) series. It surpasses the opening-day figures of the previously released “Spider-Man: Homecoming” (2017, 545,302 viewers), “Spider-Man: Far From Home” (2019, 674,432 viewers), and “Spider-Man: No Way Home” (2021, 634,962 viewers). Furthermore, these figures surpass not only the opening record of *Avatar: The Way of Water* (2022, 359,031 viewers) but also that of *Frozen 2* (606,618 viewers), the all-time highest-grossing foreign film in Korea. Audience reactions are also positive. As of the first day of release, the CGV Golden Egg Index stood at 97%, and the Naver audience rating was 9.08, signaling a promising start at the box office. Meanwhile, Director Na Hong-jin’s *Hope*, which had been holding the top spot at the box office, added 87,948 viewers that day to take second place. Its cumulative audience count stands at 3,707,174. Third place went to *Minions & Monsters*, which drew 21,655 viewers. *Moana* took fourth place with 11,102 viewers, while *Toy Story 5* came in fifth. “Spider-Man 4” is an action blockbuster in which Peter Parker (played by Tom Holland)—forgotten by everyone following the events of “Spider-Man: No Way Home”—is plunged into even deeper turmoil by the appearance of a mysterious enemy who remembers his true identity and by gaining uncontrollable powers due to a DNA mutation, as he faces a new threat to protect those he loves.
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…
